JP2012526854A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526854A5
JP2012526854A5 JP2012511068A JP2012511068A JP2012526854A5 JP 2012526854 A5 JP2012526854 A5 JP 2012526854A5 JP 2012511068 A JP2012511068 A JP 2012511068A JP 2012511068 A JP2012511068 A JP 2012511068A JP 2012526854 A5 JP2012526854 A5 JP 2012526854A5
Authority
JP
Japan
Prior art keywords
dispensing device
pharmaceutical composition
analgesic pharmaceutical
dexmedetomidine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012511068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526854A (ja
JP6172938B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/035136 external-priority patent/WO2010132882A2/en
Publication of JP2012526854A publication Critical patent/JP2012526854A/ja
Publication of JP2012526854A5 publication Critical patent/JP2012526854A5/ja
Application granted granted Critical
Publication of JP6172938B2 publication Critical patent/JP6172938B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012511068A 2009-05-15 2010-05-17 デクスメデトミジンの舌下組成物およびその使用方法 Expired - Fee Related JP6172938B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17873009P 2009-05-15 2009-05-15
US61/178,730 2009-05-15
PCT/US2010/035136 WO2010132882A2 (en) 2009-05-15 2010-05-17 Sublingual dexmedetomidine compositions and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015179975A Division JP2016029055A (ja) 2009-05-15 2015-09-11 デクスメデトミジンの舌下組成物およびその使用方法

Publications (3)

Publication Number Publication Date
JP2012526854A JP2012526854A (ja) 2012-11-01
JP2012526854A5 true JP2012526854A5 (enExample) 2013-07-04
JP6172938B2 JP6172938B2 (ja) 2017-08-02

Family

ID=43085620

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012511068A Expired - Fee Related JP6172938B2 (ja) 2009-05-15 2010-05-17 デクスメデトミジンの舌下組成物およびその使用方法
JP2015179975A Pending JP2016029055A (ja) 2009-05-15 2015-09-11 デクスメデトミジンの舌下組成物およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015179975A Pending JP2016029055A (ja) 2009-05-15 2015-09-11 デクスメデトミジンの舌下組成物およびその使用方法

Country Status (21)

Country Link
US (1) US20110021588A1 (enExample)
EP (2) EP2429521B1 (enExample)
JP (2) JP6172938B2 (enExample)
KR (1) KR101859486B1 (enExample)
CN (2) CN102639131A (enExample)
AU (1) AU2010248776B2 (enExample)
BR (1) BRPI1010567A2 (enExample)
CA (1) CA2762107A1 (enExample)
CL (1) CL2011002858A1 (enExample)
CO (1) CO6460767A2 (enExample)
CR (1) CR20110596A (enExample)
DO (1) DOP2011000354A (enExample)
EC (1) ECSP11011459A (enExample)
HN (1) HN2011003011A (enExample)
IL (1) IL216159A (enExample)
MX (1) MX2011011950A (enExample)
NZ (1) NZ596976A (enExample)
PE (1) PE20120713A1 (enExample)
RU (1) RU2572692C2 (enExample)
SG (1) SG175979A1 (enExample)
WO (1) WO2010132882A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
CN104470516A (zh) * 2011-12-11 2015-03-25 瑞克欧制药有限公司 鼻内右美托咪定组合物和其使用方法
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
CA2865593A1 (en) * 2012-02-27 2013-09-06 Eye Therapies Llc Compositions and methods for the treatment of migraine
NZ706990A (en) * 2012-10-15 2017-12-22 Orion Corp A veterinary method of alleviating noise aversion
EP2792352A1 (en) * 2013-04-16 2014-10-22 Laboratorios Del. Dr. Esteve, S.A. Alpha-2 adrenoreceptor and sigma receptor ligand combinations
US20150273215A1 (en) * 2014-03-26 2015-10-01 Pacesetter, Inc. Systems and methods for assessment of pain and other parameters during trial neurostimulation
TWI704933B (zh) * 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
CN105764496B (zh) 2013-10-07 2020-09-25 帝国制药美国公司 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物
RU2557882C1 (ru) * 2014-07-08 2015-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО АГМА Минздрава России) Способ проведения премедикации при плановом хирургическом лечении
MA41689A (fr) * 2014-10-15 2017-08-22 Bioxcel Corp Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
ES2879298T3 (es) * 2016-12-13 2021-11-22 Orion Corp Dexmedetomidina o medetomidina para su uso en el tratamiento de la ansiedad por separación en perro
CA3045043A1 (en) * 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
CN115154440A (zh) 2018-06-27 2022-10-11 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
WO2020176807A1 (en) 2019-02-27 2020-09-03 Vanderbilt University Methods of treating trigeminal nerve pain
CN116474218A (zh) * 2019-06-28 2023-07-25 四川普锐特药业有限公司 保持给药均一度的药物流体分配器及右美托咪定鼻喷器
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN113827590A (zh) * 2020-06-08 2021-12-24 四川普锐特药业有限公司 右美托咪定在助眠药物制备中的应用
US20220031664A1 (en) * 2020-07-28 2022-02-03 Melt Pharmaceuticals, Inc. Pharmaceutical compositions comprising antiemetics and alpha-2-adrenergic receptor agonists and methods of using the same for anesthesiological applications
EP4583871A1 (en) * 2022-09-11 2025-07-16 BioXcel Therapeutics, Inc. Methods for treating agitation in community settings
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN118542852B (zh) * 2024-07-30 2024-10-01 山东则正医药技术有限公司 包含经口给药的右美托咪定舌下膜组合物及其制备方法和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
CN1321086A (zh) * 1998-10-02 2001-11-07 3M创新有限公司 粘膜型药物送递系统及其动物运用
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
AUPR184500A0 (en) * 2000-12-01 2001-01-04 Drug Delivery Solutions Pty Ltd Dispensing device
US20030022926A1 (en) * 2001-05-07 2003-01-30 Lavand'homme Patricia Method for treating neuropathic pain and pharmaceutical preparation therefor
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
IL147921A0 (en) * 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20090117054A1 (en) * 2005-03-29 2009-05-07 University Of Kentucky Research Foundation Sublingual spray for the treatment of pain
MX374396B (es) * 2006-01-25 2025-03-06 Insys Therapeutics Inc Rocio de fentanilo sublingual.
EP1986642B1 (en) * 2006-02-13 2013-11-13 Orient Pharma (Samoa) Co, Ltd Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
CN101057830A (zh) * 2007-05-10 2007-10-24 北京天川军威医药技术开发有限公司 盐酸纳洛酮舌下喷雾给药系统或组合物及其制备方法

Similar Documents

Publication Publication Date Title
JP2012526854A5 (enExample)
IL216494A0 (en) Pharmaceutical dosage form oral administration of a bcl 2 family inhibitor
ES2551307T3 (es) Composición de inhalación que contiene aclidinio para tratamiento de enfermedad pulmonar obstructiva crónica
JP2012502037A5 (enExample)
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
CL2007003609A1 (es) Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
WO2013090278A3 (en) Intranasal dexmedetomidine compositions and methods of use thereof
PL2063861T3 (pl) Jednostka dawkowania do podawania podjęzykowego, podpoliczkowego lub doustnego nierozpuszczalnych w wodzie substancji aktywnych farmaceutycznie
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
JP2013121983A5 (enExample)
IL196854A (en) Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs
ECSP11011289A (es) Formulaciones galénicas de compuestos orgánicos
BRPI0908292A2 (pt) "métodos e composições para administração oral de exenatida"
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BRPI0807943A2 (pt) Composição farmacêutica ou nutracêutica e métodos para melhorar a administração de um ingrediente farmacêutico pela mucosa oral e para supressão de apetite
JP2015523407A5 (enExample)
IL184148A (en) History of triazole is claimed as oxytocin antagonists, their pharmacological preparations and their use in the preparation of drugs for the treatment of disorders in which the inhibition of oxytocin gives a beneficial effect
BRPI0807285A2 (pt) "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
MX2010003441A (es) Formulaciones galenicas de alisquireno y valsartan.
WO2011056240A3 (en) Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
JP2011527299A5 (enExample)